moxifloxacin has been researched along with 2019 Novel Coronavirus Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 22 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogan, A; Donmez, F | 1 |
| Arya, SK; Goel, I; Jha, UP; Nayyar, S; Rehman, O | 1 |
| Arunkumar, WV; Lagvankar, M; Patnaik, G | 1 |
| Gürelik, G; Özdek, Ş; Özdemir, HB; Yüksel, M | 1 |
| Lončarić, K; Radmilović, M; Tadić, R; Vatavuk, Z | 1 |
| Bulychev, VV; Bulycheva, EV; Pashkova, NA | 1 |
| Eid, M; El-Sayed, A; Elmansi, HM; Shalan, S | 1 |
| Aral, M; Ates, S; Doganer, A; Nazik, S; Orak, F; Yalcinkaya, KT | 1 |
| Cao, Y; Xu, S; Zhou, M; Zhu, F | 1 |
| Chen, Q; Dai, Y; Gao, G; Han, W; Li, J; Li, L; Li, X; Liu, C; Quan, B; Wang, C; Yang, J; Zhang, G; Zhang, J; Zhang, Z; Zheng, W | 1 |
| Ding, D; Yao, W; Zhu, C | 1 |
| Li, J; Liu, B; Song, D; Zhang, L | 1 |
| Chen, T; Hu, Y; Li, L; Liu, H; Liu, M; Wang, F; Wang, Y; Xia, H; Zhang, L; Zhao, S | 1 |
| Ozturker, ZK | 1 |
| Mishra, B; Nayak, B; Panigrahi, MK; Poddar, C; Tripathy, S | 1 |
| Cao, J; Fan, L; He, F; Hu, K; Lei, M; Luo, Q; Qin, S; Shao, X; Yang, L; Yu, N | 1 |
| Astowo, P; Irawan, B; Magdalena, L; Maha, IHRT; Muthalib, A; Rinaldi, I; Susanto, N; Wicaksono, S | 1 |
| Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J | 1 |
| Luo, S; Tian, M; Wang, L; Xia, W; Zeng, Y; Zha, Y; Zhang, K; Zhang, X | 1 |
| Beberok, A; Boryczka, S; Marciniec, K; Pęcak, P; Wrześniok, D | 1 |
| Tang, L; Zeng, X | 1 |
| Chen, Y; Chu, S; Wang, J; Yan, C; Yu, L | 1 |
2 review(s) available for moxifloxacin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Conjunctivitis as sole symptom of COVID-19: A case report and review of literature.
Topics: Administration, Ophthalmic; Adult; Anti-Bacterial Agents; Conjunctivitis, Viral; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Eye Infections, Viral; Humans; Male; Moxifloxacin; Nurses; Occupational Exposure; Ophthalmic Solutions; Pneumonia, Viral; RNA, Viral; SARS-CoV-2; Tears; Tomography, X-Ray Computed | 2021 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Lung; Lupus Erythematosus, Systemic; Moxifloxacin; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Prednisone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; RNA, Viral; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
20 other study(ies) available for moxifloxacin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues.
Topics: Adenosine Deaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Ciprofloxacin; COVID-19; Creatinine; Fluoroquinolones; Glucose; Glutathione; Glutathione Peroxidase; Levofloxacin; Lipid Peroxidation; Malondialdehyde; Moxifloxacin; Nalidixic Acid; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; SARS-CoV-2; Superoxide Dismutase; Triglycerides | 2022 |
Herpes Zoster Ophthalmicus After COVID-19 Vaccination: Chance Occurrence or More?
Topics: Acyclovir; Administration, Ophthalmic; Administration, Oral; Adult; Anti-Bacterial Agents; Antiviral Agents; ChAdOx1 nCoV-19; Conjunctivitis, Viral; COVID-19; Drug Therapy, Combination; Herpes Zoster Ophthalmicus; Humans; Male; Moxifloxacin; SARS-CoV-2; Vaccination; Valacyclovir; Visual Acuity | 2022 |
Bilateral Acute Depigmentation of Iris (BADI) Post COVID Infection following Systemic Moxifloxacin Therapy.
Topics: Adult; Aged; COVID-19; Female; Humans; Iris; Iris Diseases; Moxifloxacin; RNA, Viral; SARS-CoV-2 | 2023 |
Bilateral acute Iris transillumination after COVID-19 pneumonia.
Topics: Aged; COVID-19; Humans; Iris; Iris Diseases; Male; Moxifloxacin; Transillumination | 2023 |
Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Topics: COVID-19; Glaucoma; Humans; Iris; Iris Diseases; Moxifloxacin; Syndrome; Transillumination | 2023 |
[The problem of formation of new risks of medicinal resistance of patients with tuberculosis in condition of active use of antibiotics by population under COVID-19].
Topics: Anti-Infective Agents; Antitubercular Agents; Azithromycin; COVID-19; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Mycobacterium tuberculosis; Pandemics; Quinolones; Tuberculosis | 2023 |
Validated spectrofluorimetric assay of two co-administered drug mixtures containing hydroxychloroquine with either moxifloxacin or ofloxacin as a drug regimen for hospital-acquired pneumonia in patients with COVID-19.
Topics: Anti-Bacterial Agents; COVID-19; COVID-19 Drug Treatment; Hospitals; Humans; Hydroxychloroquine; Moxifloxacin; Ofloxacin; Pandemics; Spectrometry, Fluorescence | 2023 |
The Relationship of Comorbid Diseases and Empirical Antibiotic Usage with Superinfection in COVID-19 Patients.
Topics: Anti-Bacterial Agents; Azithromycin; COVID-19; Humans; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Superinfection | 2023 |
Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
Topics: Anti-HIV Agents; Betacoronavirus; China; Clinical Laboratory Techniques; Coinfection; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus, Type 2; Drug Combinations; gamma-Globulins; HIV; HIV Infections; Humans; Lopinavir; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.
Topics: Adolescent; Adult; Betacoronavirus; China; Clinical Laboratory Techniques; Contact Tracing; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Humans; Interferon alpha-2; Lopinavir; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Oropharynx; Oxygen; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes; Tomography, X-Ray Computed | 2020 |
A Cured Patient With 2019-nCoV Pneumonia.
Topics: Aged; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Humans; Moxifloxacin; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.
Topics: Acids, Carbocyclic; Aged; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cyclopentanes; Extracorporeal Membrane Oxygenation; Female; Guanidines; Humans; Indoles; Lung; Moxifloxacin; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Virus Shedding | 2020 |
Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.
Topics: Aged; Anti-Bacterial Agents; Conjunctiva; Conjunctivitis, Viral; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Eye Infections, Viral; Flow Cytometry; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 6, Human; High-Throughput Nucleotide Sequencing; HIV Protease Inhibitors; Humans; Lacrimal Duct Obstruction; Lopinavir; Male; Medicine, Chinese Traditional; Moxifloxacin; Nasopharynx; Nucleic Acids; Polymerase Chain Reaction; Ritonavir; RNA, Viral; Roseolovirus Infections; SARS-CoV-2; Tears | 2020 |
Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia.
Topics: Aged; Anti-Bacterial Agents; Betacoronavirus; Conjunctivitis, Viral; Coronavirus Infections; COVID-19; Eye Infections, Viral; Follow-Up Studies; Humans; Lubricants; Male; Moxifloxacin; Ophthalmic Solutions; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2 | 2020 |
The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.
Topics: Anti-Infective Agents; Antineoplastic Agents; Betacoronavirus; Breast Neoplasms; Clinical Laboratory Techniques; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Humans; Mastectomy; Middle Aged; Moxifloxacin; Pandemics; Pneumonia, Viral; Procalcitonin; Radiography, Thoracic; SARS-CoV-2; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2020 |
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Moxifloxacin; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Qi; Ritonavir; SARS-CoV-2 | 2020 |
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.
Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2 | 2020 |
One-year Follow-up after Severe SARS-CoV-2 Pneumonia.
Topics: Anti-Bacterial Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Follow-Up Studies; Humans; Lung; Middle Aged; Moxifloxacin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed | 2021 |
The differential diagnosis of pneumonia in two patients infected by atypical pathogens.
Topics: Adolescent; Adult; COVID-19; Diagnosis, Differential; DNA, Bacterial; Feces; Female; Humans; Male; Metagenomics; Moxifloxacin; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Sputum; Young Adult | 2021 |